Teva Pharmaceutical says rival generic drugmaker Mylan is engaging in a “desperate attempt” to keep its board and shareholders from considering Teva’s $40 billion-plus takeover offer. The claim, ...

June 13 (Reuters) - Mylan Nv: * Mylan's letter to shareholders dated june 12 says Teva’s expression of interest was simply not right for Mylan and its stakeholders * Mylan - despite Mylan’s leadership ...

Oct 16 (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd sued rival Mylan Inc , alleging that Mylan's application to market a copycat version of Teva's multiple sclerosis drug Copaxone ...

David Beard, The Dominion Post, Morgantown, W.Va. July 4, 2021 at 10:32 PM Jul. 4—MORGANTOWN — The tangled world of generic pharmaceuticals took another twist last week, as Mylan Pharmaceuticals filed ...

Mylan’s biggest shareholder is backing the generic drugmaker’s plan to remain a stand-alone company as it fights a takeover bid from larger rival Teva Pharmaceutical. Abbott Laboratories also says it ...